|
|
Previous Article | Table of Contents | Next Article 
Blood, 15 May 2001, Vol. 97, No. 10, pp. 2979-2982
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
Polymorphisms of clotting factors modify the risk for primary
intracranial hemorrhage
Javier Corral,
Juan
Antonio Iniesta,
Rocio González-Conejero,
Marino Villalón, and
Vicente Vicente
From the Emergency Service Hospital Virgen de la
Arrixaca; the Neurology Division and the Hematology and Medical
Oncology Service, Hospital General Universitario, Murcia, Spain.
Intracranial hemorrhage is the third most frequent cause of
cerebrovascular disease, but few genetic risk factors have been associated with its development. Recently, it has been reported that
some polymorphisms that affect clotting factors increase the risk for
thrombosis. However, reports have analyzed the effect of polymorphisms
influencing the hemostatic state in bleeding disorders insufficiently.
A case-control study was conducted of 201 patients with spontaneous
intracranial hemorrhage and 201 control subjects matched for age, race,
sex, and selected risk factors (hypertension, smoking, and alcohol
consumption). Genomic polymerase chain reaction was used to analyze the
prevalence of 4 polymorphisms: factor V Leiden, prothrombin 20210A,
factor VII 323 Del/Ins of a decanucleotide, and factor
XIII V34L. Subjects with factor V Leiden had decreased risk for
spontaneous intracranial hemorrhage (odds ratio, 0.19; 95% confidence
interval, 0.03-0.95). The frequency of the prothrombin 20210A/G
genotype was also lower among patients than controls (1.5% vs 3%,
respectively). Moreover, carriers of the 323 Ins allele of factor VII
had a 1.54-fold risk for intracranial hemorrhage (95% CI, 1.03-2.72).
Finally, no significant differences were observed in the prevalence of factor XIII V34L polymorphism between patients and controls. Therefore, new genetic factors affecting the risk for spontaneous intracranial hemorrhage were identified. These data, together with the relevance of
these polymorphisms in thrombotic diseases, support the idea that a
polymorphism may play opposite roles in thrombosis and hemorrhage,
suggesting an explanation for the high frequency of these polymorphisms
in the general population.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Letter in Blood Online:
-
Factor V Leiden and intracranial hemorrhage
- J. Nathan Hagstrom
Blood 2001 98: 2875.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
D. C. Herak, M. R. Antolic, J. L. Krleza, M. Pavic, S. Dodig, V. Duranovic, A. B. Brkic, and R. Zadro
Inherited Prothrombotic Risk Factors in Children With Stroke, Transient Ischemic Attack, or Migraine
Pediatrics,
April 1, 2009;
123(4):
e653 - e660.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Franchini and P. M. Mannucci
Interactions between genotype and phenotype in bleeding and thrombosis
Haematologica,
May 1, 2008;
93(5):
649 - 652.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Navarro-Nunez, M. L. Lozano, J. Rivera, J. Corral, V. Roldan, R. Gonzalez-Conejero, J. A. Iniesta, J. Montaner, V. Vicente, and C. Martinez
The association of the {beta}1-tubulin Q43P polymorphism with intracerebral hemorrhage in men
Haematologica,
April 1, 2007;
92(4):
513 - 518.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Hartel, I. Konig, S. Koster, E. Kattner, E. Kuhls, H. Kuster, J. Moller, D. Muller, A. Kribs, H. Segerer, et al.
Genetic Polymorphisms of Hemostasis Genes and Primary Outcome of Very Low Birth Weight Infants
Pediatrics,
August 1, 2006;
118(2):
683 - 689.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. L. Young and G.-Y. Yang
Are There Genetic Influences on Sporadic Brain Arteriovenous Malformations?
Stroke,
November 1, 2004;
35(11_suppl_1):
2740 - 2745.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Iniesta, R. Gonzalez-Conejero, C. Piqueras, V. Vicente, and J. Corral
Platelet GP IIIa Polymorphism HPA-1 (PlA) Protects Against Subarachnoid Hemorrhage
Stroke,
October 1, 2004;
35(10):
2282 - 2286.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Gonzalez-Conejero, J. Corral, V. Roldan, C. Martinez, F. Marin, J. Rivera, J. A. Iniesta, M. L. Lozano, P. Marco, and V. Vicente
A common polymorphism in the annexin V Kozak sequence (-1C>T) increases translation efficiency and plasma levels of annexin V, and decreases the risk of myocardial infarction in young patients
Blood,
August 28, 2002;
100(6):
2081 - 2086.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. S. Ariens, T.-S. Lai, J. W. Weisel, C. S. Greenberg, and P. J. Grant
Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms
Blood,
July 18, 2002;
100(3):
743 - 754.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Gerlach, F. Tolle, A. Raabe, M. Zimmermann, A. Siegemund, and V. Seifert
Increased Risk for Postoperative Hemorrhage After Intracranial Surgery in Patients With Decreased Factor XIII Activity: Implications of a Prospective Study
Stroke,
June 1, 2002;
33(6):
1618 - 1623.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Weger, W. Renner, O. Stanger, O. Schmut, H. Deutschmann, T. C. Wascher, and A. Haas
Role of Factor XIII Val34Leu Polymorphism in Retinal Artery Occlusion
Stroke,
December 1, 2001;
32(12):
2759 - 2761.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. Reiner, S. M. Schwartz, M. B. Frank, W.T. Longstreth Jr, L. A. Hindorff, G. Teramura, F. R. Rosendaal, L. K. Gaur, B. M. Psaty, D. S. Siscovick, et al.
Polymorphisms of Coagulation Factor XIII Subunit A and Risk of Nonfatal Hemorrhagic Stroke in Young White Women Editorial Comment
Stroke,
November 1, 2001;
32(11):
2580 - 2587.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. N. Hagstrom
Factor V Leiden and intracranial hemorrhage
Blood,
November 1, 2001;
98(9):
2875 - 2875.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Catto
Genetic aspects of the hemostatic system in cerebrovascular disease
Neurology,
September 1, 2001;
57(90002):
S24 - 30.
[Abstract]
[Full Text]
|
 |
|
|
|